Topiramate (2013-09-13)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| KE4383 | Topiramate, 100.0 mg | - Recalling Firm
- Sivem Pharmaceuticals ULC
- 4705 Dobrin Street
- Ville Saint-Laurent
- H4R 2P7
- Quebec
- CANADA
- Marketing Authorization Holder
- Sivem Pharmaceuticals ULC
- 4705 Dobrin Street
- Ville Saint-Laurent
- H4R 2P7
- Quebec
- CANADA
| Tablet | DIN 02389487 | Topiramate, 100.0 mg |
| KE4385 | Topiramate, 25.0 mg | - Recalling Firm
- Sivem Pharmaceuticals ULC
- 4705 Dobrin Street
- Ville Saint-Laurent
- H4R 2P7
- Quebec
- CANADA
- Marketing Authorization Holder
- Sivem Pharmaceuticals ULC
- 4705 Dobrin Street
- Ville Saint-Laurent
- H4R 2P7
- Quebec
- CANADA
| Tablet | DIN 02389460 | Topiramate, 25.0 mg |
Recalled Products
A. Topiramate, 25.0 mg
B. Topiramate, 100.0 mg
The indicated lots may not meet the registered limit for sulfate toward the end of shelf life.
Wholesalers in the province of Quebec.